Citi raises Novo Nordisk stock target despite ’mixed’ results
In short
Citi updated its financial outlook for Novo Nordisk by boosting the equity's target price. This positive revision arrived immediately following an earnings release that exhibited mixed operational performance across the firm. By lifting the target despite the uneven numbers, the bank highlights a durable investment thesis that looks past the immediate quarter.
Key points
- Novo Nordisk secured a target price increase from financial analysts at Citi.: Novo Nordisk secured a target price increase from financial analysts at Citi.
- Recent company performance reports were formally characterized by market observers as mix…: Recent company performance reports were formally characterized by market observers as mixed.
- Institutional price targets can continue to climb higher even through uneven quarterly re…: Institutional price targets can continue to climb higher even through uneven quarterly results.